Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
- PMID: 8353913
- DOI: 10.1161/01.cir.88.3.837
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
Abstract
Background: Peripheral arterial disease measured noninvasively by the ankle-arm index (AAI) is common in older adults, largely asymptomatic, and associated with clinically manifest cardiovascular disease (CVD). The criteria for an abnormal AAI have varied in previous studies. To determine whether there is an inverse dose-response relation between the AAI and clinical CVD, subclinical disease, and risk factors, we examined the relation of the AAI to cardiovascular risk factors, other noninvasive measures of subclinical atherosclerosis using carotid ultrasound, echocardiography and electrocardiography, and clinical CVD.
Methods and results: The AAI was measured in 5084 participants > or = 65 years old at the baseline examination of the Cardiovascular Health Study. All subjects had detailed assessment of prevalent CVD, measures of cardiovascular risk factors, and noninvasive measures of disease. Participants were stratified by baseline clinical CVD status and AAI (< 0.8, > or = 0.8 to < 0.9, > or = 0.9 to < 1.0, > or = 1.0 to < 1.5). Analyses tested for a dose-response relation of the AAI with clinical CVD, risk factors, and subclinical disease. The cumulative frequency of a low AAI was 7.4% of participants < 0.8, 12.4% < 0.9, and 23.6% < 1.0. participants with an AAI < 0.8 were more than twice as likely as those with an AAI of 1.0 to 1.5 to have a history of myocardial infarction, angina, congestive heart failure, stroke, or transient ischemic attack (all P < .01). In participants free of clinical CVD at baseline, the AAI was inversely related to history of hypertension, history of diabetes, and smoking, as well as systolic blood pressure, serum creatinine, fasting glucose, fasting insulin, measures of pulmonary function, and fibrinogen level (all P < .01). Risk factor associations with the AAI were similar in men and women free of CVD except for serum total and low-density lipoprotein cholesterol, which were inversely associated with AAI level only in women. Risk factors associated with an AAI of < 1.0 in multivariate analysis included smoking (odds ratio [OR], 2.55), history of diabetes (OR, 3.84), increasing age (OR, 1.54), and nonwhite race (OR, 2.36). In the 3372 participants free of clinical CVD, other noninvasive measures of subclinical CVD, including carotid stenosis by duplex scanning, segmental wall motion abnormalities by echocardiogram, and major ECG abnormalities were inversely related to the AAI (all P < .01).
Conclusions: There was an inverse dose-response relation of the AAI with CVD risk factors and subclinical and clinical CVD among older adults. The lower the AAI, the greater the increase in CVD risk; however, even those with modest, asymptomatic reductions in the AAI (0.8 to 1.0) appear to be at increased risk of CVD.
Similar articles
-
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):538-45. doi: 10.1161/01.atv.19.3.538. Arterioscler Thromb Vasc Biol. 1999. PMID: 10073955
-
Mortality over four years in SHEP participants with a low ankle-arm index.J Am Geriatr Soc. 1997 Dec;45(12):1472-8. doi: 10.1111/j.1532-5415.1997.tb03198.x. J Am Geriatr Soc. 1997. PMID: 9400557
-
Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1269-79. doi: 10.1161/01.atv.15.9.1269. Arterioscler Thromb Vasc Biol. 1995. PMID: 7670938
-
Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure.Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:199-212. doi: 10.1023/a:1007792820944. Cardiovasc Drugs Ther. 1997. PMID: 9211012 Review.
-
Smoking and cardiovascular disease.Am J Med. 1992 Jul 15;93(1A):8S-12S. doi: 10.1016/0002-9343(92)90620-q. Am J Med. 1992. PMID: 1497005 Review.
Cited by
-
Global disease burden and its attributable risk factors of peripheral arterial disease.Sci Rep. 2023 Nov 14;13(1):19898. doi: 10.1038/s41598-023-47028-5. Sci Rep. 2023. PMID: 37963985 Free PMC article.
-
The usefulness of brachial-ankle pulse wave velocity in predicting long-term cardiovascular events in younger patients.Heart Vessels. 2017 Jun;32(6):660-667. doi: 10.1007/s00380-016-0919-6. Epub 2016 Nov 7. Heart Vessels. 2017. PMID: 27822742
-
Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods.Circ Cardiovasc Interv. 2022 Mar;15(3):e011092. doi: 10.1161/CIRCINTERVENTIONS.121.011092. Epub 2022 Feb 18. Circ Cardiovasc Interv. 2022. PMID: 35176872 Free PMC article.
-
Peripheral artery disease and osteoporosis: Not only age‑related (Review).Mol Med Rep. 2018 Dec;18(6):4787-4792. doi: 10.3892/mmr.2018.9512. Epub 2018 Sep 27. Mol Med Rep. 2018. PMID: 30272311 Free PMC article. Review.
-
[Can we benefit from determination of the ankle-arm index in primary care consultations?].Aten Primaria. 2006 Oct 15;38(6):358-61. doi: 10.1157/13093375. Aten Primaria. 2006. PMID: 17173802 Free PMC article. Spanish. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources